The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Stable antibody expression at therapeutic levels using the 2A peptide
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Hitoshi, N., Ken-ichi, Y., & Jun-ichi, M. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,134
Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,727
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Szymczak, A. L., Workman, C. J., Wang, Y., Vignali, K. M., Dilioglou, S., Vanin, E. F., & Vignali, D. A. A. (2004) · Nature Biotechnology · doi:10.1038/nbt957 · Cited by 1,059
Donnelly, M. L. L., Luke, G., Mehrotra, A., Li, X., Hughes, L. E., Gani, D., & Ryan, M. D. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-5-1013 · Cited by 798
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
Manno, C. S., Chew, A. J., Hutchison, S., Larson, P. J., Herzog, R. W., Arruda, V. R., Tai, S. J., Ragni, M. V., Thompson, A., Ozelo, M., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3296 · Cited by 749
Prewett, M. C., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K. D., Overholser, J. C., Hooper, A. T., Pytowski, B., Witte, L., et al. (1999) · PubMed · Cited by 713
Davis, T. A., Grillo-López, A. J., White, C. A., McLaughlin, P., Czuczman, M. S., Link, B. K., Maloney, D. G., Weaver, R. L., Rosenberg, J., & Levy, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3135 · Cited by 687
Mizuguchi, H., Xu, Z., Ishii-Watabe, A., Uchida, E., & Hayakawa, T. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0050 · Cited by 559
Ryan, M. D., King, A. M. Q., & Thomas, G. P. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-11-2727 · Cited by 477
Hudson, P. J., & Souriau, C. (2003) · Nature Medicine · doi:10.1038/nm0103-129 · Cited by 398
Moss, R. B., Rodman, D., Spencer, L. T., Aitken, M. L., Zeitlin, P. L., Waltz, D., Milla, C., Brody, A. S., Clancy, J. P., Ramsey, B., et al. (2004) · Chest · doi:10.1378/chest.125.2.509 · Cited by 390
Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein.
Ryan, M. D., & Drew, J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06337.x · Cited by 378
Grimm, D., & Kay, M. (2003) · Current Gene Therapy · doi:10.2174/1566523034578285 · Cited by 350
Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat Model
Luo, J., Kaplitt, M. G., Fitzsimons, H. L., Zuzga, D. S., Liu, Y., Oshinsky, M. L., & During, M. J. (2002) · Science · doi:10.1126/science.1074549 · Cited by 325
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
Jooss, K., & Chirmule, N. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302037 · Cited by 277
Self-citationJanson, C., McPhee, S., Bilaniuk, L., Haselgrove, J., Testaiuti, M., Freese, A., Wang, D.-J., Shera, D., Hurh, P., Rupin, J., et al. (2002) · Human Gene Therapy · doi:10.1089/104303402760128612 · Cited by 255
Lin, Y. S., Nguyen, C., Mendoza, J.-L., Escandon, E., Fei, D., Meng, Y. G., & Modi, N. B. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37962-5 · Cited by 255
Green, L. L. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00137-4 · Cited by 229
Jang, S. K., Pestova, T. V., Hellen, C. U. T., Witherell, G. W., & Wimmer, E. (1990) · Enzyme · doi:10.1159/000468766 · Cited by 204
de Felipe, P., Hughes, L. E., Ryan, M. D., & Brown, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211644200 · Cited by 167
Flotte, T. R., Brantly, M., Spencer, L. T., Byrne, B. J., Spencer, C. T., Baker, D. J., & Humphries, M. R. (2004) · Human Gene Therapy · doi:10.1089/10430340460732490 · Cited by 150
A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1
Armbruster, C., Stiegler, G. M., Vcelar, B. A., Jäger, W. R., Michael, N. L., Vetter, N., & Katinger, H. W. D. (2002) · AIDS · doi:10.1097/00002030-200201250-00012 · Cited by 130
Lewis, A. D., Chen, R., Montefiori, D. C., Johnson, P. R., & Clark, K. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8769-8775.2002 · Cited by 124
Flotte, T. R. (2004) · Human Gene Therapy · doi:10.1089/1043034041361190 · Cited by 91
Recombinant Adeno-Associated Virus As Delivery Vector for Gene Therapy—A Review
Yang, L. (2004) · Stem Cells and Development · doi:10.1089/154732804773099335 · Cited by 81
Safety of adeno-associated virus gene therapy vectors: a current evaluation
Monahan, P. E., Jooss, K. U., & Sands, M. S. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.1.79 · Cited by 67
Self-citationIn Vitro and In Vivo Secretion of Cloned Antibodies by Genetically Modified Myogenic Cells
Noël, D., Pelegrin, M., Marin, M., Biard-Piechaczyk, M., Ourlin, J., Mani, J., & Piechaczyk, M. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.10-1219 · Cited by 41
Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation
Perez, N., Bigey, P., Scherman, D., Danos, O., Piechaczyk, M., & Pelegrín, M. (2004) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-2-2 · Cited by 41
High In Vivo Production of a Model Monoclonal Antibody on Adenoviral Gene Transfer
Noël, D., Pelegrín, M., Kramer, S., Jacquet, C., Skander, N., & Piechaczyk, M. (2002) · Human Gene Therapy · doi:10.1089/10430340260185111 · Cited by 35
Therapeutic Antibody Gene Transfer: An Active Approach to Passive Immunity
Bakker, J. M., Bleeker, W. K., & Parren, P. W. H. I. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.06.865 · Cited by 32
Cited by
Precise genome modification in the crop species Zea mays using zinc-finger nucleases
Shukla, V. K., Doyon, Y., Miller, J. C., DeKelver, R. C., Moehle, E. A., Worden, S. E., Mitchell, J. C., Arnold, N. L., Gopalan, S., Meng, X., et al. (2009) · Nature · doi:10.1038/nature07992 · Cited by 958
PD-1 signaling in primary T cells
Riley, J. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00767.x · Cited by 778
“The use of the picornavirus-like 2A ‘self-cleaving’ peptide facilitates signal transduction studies in primary cells, because multiple gene products can be introduced using a single vector (90).”
BackgroundAntibody-based protection against HIV infection by vectored immunoprophylaxis
Balazs, A. B., Chen, J., Hong, C. M., Rao, D. S., Yang, L., & Baltimore, D. (2012) · Nature · doi:10.1038/nature10660 · Cited by 545
E unum pluribus: multiple proteins from a self-processing polyprotein
de Felipe, P., Luke, G. A., Hughes, L. E., Gani, D., Halpin, C., & Ryan, M. D. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.12.006 · Cited by 358
A synthetic sex ratio distortion system for the control of the human malaria mosquito
Galizi, R., Doyle, L. A., Menichelli, M., Bernardini, F., Deredec, A., Burt, A., Stoddard, B. L., Windbichler, N., & Crisanti, A. (2014) · Nature Communications · doi:10.1038/ncomms4977 · Cited by 348
Metadata
- Authors
- Fang, J., Qian, J.-J., Yi, S., Harding, T. C., Tu, G. H., VanRoey, M., & Jooss, K.
- Venue
- Nature Biotechnology
- Published
- 2005-04-17
- Volume
- 23
- Issue
- 5
- Pages
- 584-590
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2058438178
- Cited by
- 370
- References
- 33
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.